Page last updated: 2024-08-26
4-(methylthio)-3-butenyl isothiocyanate and Liver Neoplasms
4-(methylthio)-3-butenyl isothiocyanate has been researched along with Liver Neoplasms in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hertrampf, A; Herz, C; Lamy, E; Lutz-Bonengel, S; Márton, MR; Mersch-Sundermann, V | 1 |
Other Studies
1 other study(ies) available for 4-(methylthio)-3-butenyl isothiocyanate and Liver Neoplasms
| Article | Year |
|---|---|
The MAPK pathway signals telomerase modulation in response to isothiocyanate-induced DNA damage of human liver cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; DNA Damage; Down-Regulation; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Liver Neoplasms; MAP Kinase Kinase 4; Mitogen-Activated Protein Kinase Kinases; Oxidative Stress; Signal Transduction; Telomerase | 2013 |